Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Soheila Korourian

Concepts (304)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
30
2018
1189
2.270
Why?
Carcinoma, Ductal, Breast
9
2015
91
1.510
Why?
Mastectomy, Segmental
8
2015
93
1.230
Why?
Catheter Ablation
4
2014
122
1.070
Why?
Neoplasm Recurrence, Local
7
2014
634
0.990
Why?
Sentinel Lymph Node Biopsy
15
2017
118
0.980
Why?
Mastectomy
10
2018
142
0.940
Why?
Mammary Neoplasms, Experimental
7
2010
121
0.840
Why?
Soybean Proteins
4
2023
160
0.820
Why?
Biopsy, Needle
11
2017
182
0.810
Why?
Obesity
8
2023
1125
0.800
Why?
Carcinoma in Situ
3
2008
73
0.770
Why?
Lymph Nodes
12
2017
258
0.750
Why?
Caseins
4
2023
78
0.740
Why?
9,10-Dimethyl-1,2-benzanthracene
4
2015
50
0.710
Why?
Liver
9
2023
1123
0.670
Why?
DNA, Neoplasm
1
2018
146
0.590
Why?
Isoflavones
5
2023
87
0.590
Why?
Rats, Zucker
9
2023
68
0.520
Why?
Uterine Cervical Neoplasms
3
2007
278
0.480
Why?
Receptor, erbB-2
3
2018
75
0.470
Why?
Aged
32
2018
9590
0.460
Why?
Receptors, Estrogen
4
2018
130
0.450
Why?
Dietary Supplements
2
2015
445
0.450
Why?
Arginine
1
2015
185
0.440
Why?
Middle Aged
34
2018
12460
0.430
Why?
Female
51
2018
26981
0.430
Why?
Neoplasm Staging
15
2015
750
0.430
Why?
Mammary Neoplasms, Animal
2
2015
35
0.400
Why?
Diet
2
2015
554
0.400
Why?
Ultrasonography, Mammary
4
2015
61
0.380
Why?
Fatty Liver
3
2023
130
0.370
Why?
Carcinogens
3
2015
197
0.360
Why?
Antigens, Tumor-Associated, Carbohydrate
2
2008
24
0.360
Why?
Benz(a)Anthracenes
1
2010
3
0.360
Why?
Dehydroepiandrosterone
1
2010
12
0.360
Why?
Rats
15
2023
3287
0.340
Why?
Axilla
9
2017
91
0.340
Why?
Aged, 80 and over
15
2018
3180
0.330
Why?
Lymphatic Vessels
4
2014
53
0.330
Why?
Adult
25
2018
13568
0.310
Why?
Plant Lectins
1
2008
8
0.310
Why?
Carcinoma, Ductal
1
2008
9
0.310
Why?
Prognosis
11
2017
1979
0.310
Why?
Magnetic Resonance Imaging
4
2014
1534
0.290
Why?
Technetium Tc 99m Sulfur Colloid
6
2014
31
0.290
Why?
Humans
48
2024
50389
0.290
Why?
Receptors, Progesterone
4
2018
63
0.290
Why?
Electrosurgery
1
2007
7
0.280
Why?
Clinical Competence
2
2024
397
0.280
Why?
Lymphedema
5
2017
43
0.280
Why?
Thinness
3
2017
45
0.270
Why?
Lymphatic Metastasis
12
2015
227
0.270
Why?
Cytodiagnosis
4
2015
42
0.260
Why?
Animals
19
2023
13173
0.260
Why?
Prospective Studies
12
2017
2414
0.260
Why?
Follow-Up Studies
10
2015
2219
0.260
Why?
Nipples
5
2013
33
0.250
Why?
Combined Modality Therapy
5
2014
641
0.250
Why?
Biopsy, Fine-Needle
4
2024
108
0.250
Why?
Adenocarcinoma, Mucinous
1
2005
19
0.240
Why?
Endometritis
1
2004
9
0.240
Why?
Ethanol
5
2010
336
0.240
Why?
Competency-Based Education
1
2024
28
0.230
Why?
Proteoglycans
1
2004
81
0.230
Why?
Radiopharmaceuticals
6
2014
205
0.230
Why?
Carcinoma, Intraductal, Noninfiltrating
3
2013
45
0.220
Why?
Proliferating Cell Nuclear Antigen
1
2003
68
0.220
Why?
Laser Coagulation
1
2003
26
0.220
Why?
Fellowships and Scholarships
1
2024
118
0.210
Why?
Membrane Glycoproteins
1
2004
244
0.210
Why?
Plasma Cells
1
2004
221
0.210
Why?
Lymph Node Excision
6
2017
138
0.210
Why?
Carcinoma, Lobular
3
2015
33
0.210
Why?
Neoplasm Invasiveness
5
2015
269
0.210
Why?
Coloring Agents
4
2014
70
0.210
Why?
Mammaplasty
2
2013
44
0.200
Why?
Uterine Cervical Dysplasia
3
2007
49
0.200
Why?
Infant Food
1
2002
28
0.200
Why?
Monitoring, Intraoperative
3
2014
54
0.190
Why?
Ovarian Neoplasms
1
2005
450
0.180
Why?
Immunohistochemistry
9
2017
975
0.180
Why?
Biopsy
4
2007
592
0.170
Why?
Ultrasonography, Interventional
3
2011
137
0.170
Why?
Paraffin Embedding
2
2018
52
0.170
Why?
Lung Neoplasms
3
2015
600
0.170
Why?
Body Weight
3
2017
514
0.170
Why?
Retrospective Studies
13
2015
6223
0.160
Why?
Sensitivity and Specificity
8
2015
875
0.160
Why?
Adolescent
8
2015
6475
0.160
Why?
Neoplasm Grading
3
2014
124
0.160
Why?
Tissue Fixation
1
2018
36
0.150
Why?
Specimen Handling
1
2018
54
0.150
Why?
Alanine Transaminase
3
2015
120
0.150
Why?
Rats, Sprague-Dawley
7
2015
1582
0.130
Why?
Treatment Outcome
5
2017
5230
0.130
Why?
Pulmonary Medicine
1
2015
15
0.130
Why?
Protein Hydrolysates
1
2015
6
0.130
Why?
Aspartate Aminotransferases
1
2015
47
0.130
Why?
Kaplan-Meier Estimate
2
2014
466
0.130
Why?
Plant Extracts
1
2017
166
0.120
Why?
Rosaniline Dyes
1
2014
8
0.120
Why?
Sulfotransferases
1
2015
39
0.120
Why?
Image-Guided Biopsy
1
2015
33
0.120
Why?
Dermatologic Surgical Procedures
2
2013
34
0.120
Why?
Melanoma
2
2011
281
0.120
Why?
Vacuum
2
2011
13
0.110
Why?
Young Adult
6
2015
4064
0.110
Why?
Ultrasonography, Doppler
1
2014
41
0.110
Why?
Interleukin-6
1
2015
266
0.110
Why?
Tumor Necrosis Factor-alpha
1
2015
388
0.110
Why?
Patient Care Planning
1
2013
67
0.110
Why?
Carcinoma, Adenoid Cystic
1
2013
5
0.110
Why?
Intraoperative Care
2
2011
52
0.110
Why?
Disease-Free Survival
1
2014
450
0.100
Why?
Preoperative Care
1
2014
170
0.100
Why?
Skin Neoplasms
2
2011
487
0.100
Why?
Lymphography
1
2011
9
0.100
Why?
Image Processing, Computer-Assisted
2
2003
242
0.100
Why?
Frozen Sections
1
2011
13
0.090
Why?
Liver Neoplasms
2
2005
331
0.090
Why?
Male
10
2023
25718
0.090
Why?
Cytoprotection
1
2010
34
0.090
Why?
DNA Methylation
1
2015
551
0.090
Why?
Fatty Liver, Alcoholic
1
2010
7
0.090
Why?
Drug Evaluation, Preclinical
1
2010
145
0.090
Why?
Genistein
1
2010
46
0.080
Why?
Cell Line, Tumor
3
2010
1399
0.080
Why?
Feasibility Studies
1
2011
386
0.080
Why?
Hepatocytes
2
2008
179
0.080
Why?
Pilot Projects
1
2011
704
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1003
0.080
Why?
Radionuclide Imaging
4
2011
116
0.080
Why?
Hepatitis
1
2008
21
0.070
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2007
30
0.070
Why?
Cytokines
2
2008
606
0.070
Why?
Protons
1
2007
67
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
60
0.070
Why?
Ovariectomy
1
2007
113
0.070
Why?
Organ Size
1
2007
223
0.070
Why?
Oligosaccharides
1
2005
35
0.060
Why?
Cystadenocarcinoma, Papillary
1
2005
14
0.060
Why?
Antibodies, Neoplasm
1
2005
28
0.060
Why?
Aging
1
2010
675
0.060
Why?
Omentum
1
2005
15
0.060
Why?
Uterine Neoplasms
1
2005
60
0.060
Why?
Monosaccharide Transport Proteins
1
2004
14
0.060
Why?
Eosine Yellowish-(YS)
1
2004
5
0.060
Why?
Carcinoma, Small Cell
1
2004
25
0.060
Why?
Syndecans
1
2004
34
0.060
Why?
Hematoxylin
1
2004
7
0.060
Why?
Syndecan-1
1
2004
72
0.060
Why?
Endometrium
1
2004
40
0.060
Why?
Immunoenzyme Techniques
1
2004
141
0.060
Why?
Endotoxins
1
2004
31
0.060
Why?
Carbohydrates
1
2004
40
0.060
Why?
Lymphoma, Non-Hodgkin
1
2004
58
0.060
Why?
Liver Diseases, Alcoholic
1
2004
34
0.060
Why?
Pathology
1
2024
38
0.060
Why?
Cytological Techniques
1
2003
14
0.060
Why?
Apoproteins
1
2003
14
0.050
Why?
Neoplasms, Multiple Primary
1
2003
43
0.050
Why?
Fatty Acids
1
2004
145
0.050
Why?
Dietary Fats
1
2004
126
0.050
Why?
Malondialdehyde
1
2003
50
0.050
Why?
Neoplasms
2
2004
1237
0.050
Why?
Gene Expression Regulation
1
2008
964
0.050
Why?
Gene Expression
2
2019
613
0.050
Why?
Cell Membrane
1
2004
249
0.050
Why?
Aldehydes
1
2003
82
0.050
Why?
Risk Factors
1
2011
3692
0.050
Why?
Overweight
1
2005
217
0.050
Why?
Cytochrome P-450 CYP2E1
3
2010
110
0.050
Why?
Surgical Instruments
1
2002
27
0.050
Why?
Breast Diseases
1
2002
27
0.050
Why?
Foreign-Body Migration
1
2002
32
0.050
Why?
Hematoma
3
2010
64
0.050
Why?
Education, Medical, Graduate
1
2024
213
0.050
Why?
Asia
1
2002
19
0.050
Why?
Chronic Disease
1
2004
570
0.050
Why?
Carcinoma, Squamous Cell
1
2004
325
0.050
Why?
Head and Neck Neoplasms
1
2004
282
0.050
Why?
Cost-Benefit Analysis
2
2015
270
0.050
Why?
Time Factors
1
2007
2934
0.040
Why?
Neoplasm Metastasis
2
2015
235
0.040
Why?
Cytokine Receptor Common beta Subunit
1
2019
2
0.040
Why?
Health Status
1
2002
299
0.040
Why?
Methyltransferases
1
2019
29
0.040
Why?
Apoptosis
1
2005
1094
0.040
Why?
Disease Progression
2
2015
823
0.040
Why?
Child, Preschool
1
2008
3908
0.040
Why?
Cohort Studies
2
2015
1426
0.040
Why?
Alcohol Dehydrogenase
2
2010
37
0.040
Why?
Oxidative Stress
3
2010
763
0.040
Why?
Arm
2
2009
48
0.040
Why?
Anti-Bacterial Agents
1
2004
745
0.040
Why?
Stereotaxic Techniques
2
2010
37
0.040
Why?
Polymerase Chain Reaction
1
2019
456
0.040
Why?
Risk Assessment
2
2017
1258
0.040
Why?
Disease Models, Animal
2
2015
1419
0.030
Why?
Adiponectin
1
2017
46
0.030
Why?
Feces
1
2017
131
0.030
Why?
Injections, Intralesional
2
2008
31
0.030
Why?
Reproducibility of Results
2
2015
1201
0.030
Why?
Phylogeny
1
2017
234
0.030
Why?
Lipid Metabolism
1
2017
176
0.030
Why?
Leptin
1
2017
143
0.030
Why?
Child
1
2008
6877
0.030
Why?
Cost Savings
1
2015
58
0.030
Why?
Protective Agents
1
2015
16
0.030
Why?
Taxoids
1
2015
37
0.030
Why?
MCF-7 Cells
1
2015
62
0.030
Why?
Mice, Inbred BALB C
2
2005
297
0.030
Why?
Insulin
1
2017
466
0.030
Why?
CpG Islands
1
2015
106
0.030
Why?
Infant, Newborn
1
2002
2780
0.030
Why?
Cyclophosphamide
1
2015
164
0.030
Why?
Tumor Cells, Cultured
1
2015
462
0.030
Why?
Touch
1
2013
25
0.030
Why?
Neoadjuvant Therapy
1
2015
119
0.030
Why?
Biopsy, Large-Core Needle
1
2013
33
0.030
Why?
Carcinoma
1
2015
139
0.030
Why?
Angiogenesis Inhibitors
1
2015
182
0.030
Why?
Infant
1
2002
3601
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2015
224
0.030
Why?
Radiotherapy, Adjuvant
1
2013
60
0.030
Why?
Hormones
1
2013
57
0.030
Why?
Chemotherapy, Adjuvant
1
2013
121
0.030
Why?
Injections, Intradermal
1
2011
14
0.020
Why?
X-Rays
1
2011
55
0.020
Why?
Antineoplastic Agents
2
2013
1178
0.020
Why?
United States
1
2002
4913
0.020
Why?
Cicatrix
1
2011
43
0.020
Why?
Intraoperative Period
1
2011
45
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2015
830
0.020
Why?
Diagnosis, Differential
2
2004
1042
0.020
Why?
Predictive Value of Tests
2
2004
934
0.020
Why?
Allyl Compounds
1
2010
11
0.020
Why?
Sulfides
1
2010
28
0.020
Why?
Survival Rate
1
2012
915
0.020
Why?
Chemokines
1
2010
76
0.020
Why?
Double-Blind Method
1
2011
682
0.020
Why?
Transforming Growth Factor beta1
1
2010
60
0.020
Why?
Mammary Glands, Animal
1
2010
69
0.020
Why?
Cell Division
1
2010
294
0.020
Why?
Endoplasmic Reticulum
1
2010
118
0.020
Why?
Pyrazoles
1
2010
111
0.020
Why?
Pregnancy
1
2015
2610
0.020
Why?
Tissue Extracts
1
2007
13
0.020
Why?
Least-Squares Analysis
1
2007
42
0.020
Why?
Biotransformation
1
2007
84
0.020
Why?
Enzyme Inhibitors
1
2010
378
0.020
Why?
Electrocoagulation
1
2007
12
0.020
Why?
Survival Analysis
1
2009
671
0.020
Why?
Solubility
1
2007
72
0.020
Why?
Enteral Nutrition
1
2008
149
0.020
Why?
Observer Variation
1
2007
139
0.020
Why?
Staining and Labeling
1
2007
97
0.020
Why?
Positron-Emission Tomography
1
2008
289
0.020
Why?
E-Selectin
1
2005
14
0.020
Why?
Body Weights and Measures
1
2005
17
0.020
Why?
Wheat Germ Agglutinins
1
2005
3
0.020
Why?
Vaccines, Subunit
1
2005
15
0.020
Why?
Vaccines, DNA
1
2005
11
0.020
Why?
Cross Reactions
1
2005
41
0.020
Why?
Gadolinium
1
2005
46
0.020
Why?
Cytotoxicity, Immunologic
1
2005
56
0.020
Why?
Growth Inhibitors
1
2005
27
0.020
Why?
Gene Amplification
1
2005
57
0.020
Why?
Ligands
1
2005
203
0.020
Why?
Mice
2
2005
5688
0.020
Why?
Glucose Transporter Type 1
1
2004
17
0.010
Why?
Imaging, Three-Dimensional
1
2005
152
0.010
Why?
Free Radicals
1
2004
28
0.010
Why?
Sampling Studies
1
2004
37
0.010
Why?
In Situ Hybridization, Fluorescence
1
2005
256
0.010
Why?
Enzyme Induction
1
2004
79
0.010
Why?
Corn Oil
1
2004
12
0.010
Why?
Hyperplasia
1
2004
96
0.010
Why?
Eye Neoplasms
1
2004
10
0.010
Why?
Contrast Media
1
2005
190
0.010
Why?
MART-1 Antigen
1
2004
12
0.010
Why?
Species Specificity
1
2004
192
0.010
Why?
Amino Acid Sequence
1
2005
579
0.010
Why?
Cell Proliferation
1
2008
989
0.010
Why?
Necrosis
1
2004
175
0.010
Why?
Injections
1
2003
57
0.010
Why?
Rats, Wistar
1
2004
221
0.010
Why?
Dietary Carbohydrates
1
2004
90
0.010
Why?
Molecular Sequence Data
1
2005
799
0.010
Why?
Regression Analysis
1
2004
396
0.010
Why?
Cytoplasm
1
2004
93
0.010
Why?
Energy Intake
1
2004
171
0.010
Why?
Cytochrome P-450 Enzyme System
1
2004
194
0.010
Why?
Cell Nucleus
1
2004
186
0.010
Why?
Multivariate Analysis
1
2004
583
0.010
Why?
Antigens, Neoplasm
1
2004
146
0.010
Why?
Glutathione
1
2004
297
0.010
Why?
Sex Characteristics
1
2004
198
0.010
Why?
Antioxidants
1
2004
238
0.010
Why?
Confidence Intervals
1
2002
154
0.010
Why?
Models, Theoretical
1
2002
174
0.010
Why?
Neoplasm Proteins
1
2004
321
0.010
Why?
Reoperation
1
2002
457
0.010
Why?
Korourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description